Literature DB >> 9497345

Identification of PLC210, a Caenorhabditis elegans phospholipase C, as a putative effector of Ras.

M Shibatohge1, K i Kariya, Y Liao, C D Hu, Y Watari, M Goshima, F Shima, T Kataoka.   

Abstract

Mammalian Ras proteins regulate multiple effectors including Raf, Ral guanine nucleotide dissociation stimulator (RalGDS), and phosphoinositide 3-kinase. In the nematode Caenorhabditis elegans, LIN-45 Raf has been identified by genetic analyses as an effector of LET-60 Ras. To search for other effectors in C. elegans, we performed a yeast two-hybrid screening for LET-60-binding proteins. The screening identified two cDNA clones encoding a phosphoinositide-specific phospholipase C (PI-PLC) with a predicted molecular mass of 210 kDa, designated PLC210. PLC210 possesses two additional functional domains unseen in any known PI-PLCs. One is the C-terminal Ras-associating domain bearing a structural homology with those of RalGDS and AF-6. This domain, which could be narrowed down to 100 amino acid residues, associated in vitro with human Ha-Ras in a GTP-dependent manner and competed with yeast adenylyl cyclase for binding Ha-Ras. The binding was abolished by specific mutations within the effector region of Ha-Ras. The other functional domain is the N-terminal CDC25-like domain, which possesses a structural homology to guanine nucleotide exchange proteins for Ras. These results strongly suggest that PLC210 belongs to a novel class of PI-PLC, which is a putative effector of Ras.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497345     DOI: 10.1074/jbc.273.11.6218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

Review 2.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

Review 3.  Role of phospholipase Cε in physiological phosphoinositide signaling networks.

Authors:  Alan V Smrcka; Joan Heller Brown; George G Holz
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

4.  Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon.

Authors:  Makoto Tadano; Hironori Edamatsu; Susumu Minamisawa; Utako Yokoyama; Yoshihiro Ishikawa; Noboru Suzuki; Hiromitsu Saito; Dongmei Wu; Misa Masago-Toda; Yuriko Yamawaki-Kataoka; Tomiyoshi Setsu; Toshio Terashima; Sakan Maeda; Takaya Satoh; Tohru Kataoka
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Reduction in ovulation or male sex phenotype increases long-term anoxia survival in a daf-16-independent manner in Caenorhabditis elegans.

Authors:  Alexander R Mendenhall; Michelle G LeBlanc; Desh P Mohan; Pamela A Padilla
Journal:  Physiol Genomics       Date:  2008-12-02       Impact factor: 3.107

6.  Phospholipase C isozymes as effectors of Ras superfamily GTPases.

Authors:  T Kendall Harden; Stephanie N Hicks; John Sondek
Journal:  J Lipid Res       Date:  2008-11-24       Impact factor: 5.922

Review 7.  Canonical RTK-Ras-ERK signaling and related alternative pathways.

Authors:  Meera V Sundaram
Journal:  WormBook       Date:  2013-07-11

8.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

Review 9.  G-protein signaling: back to the future.

Authors:  C R McCudden; M D Hains; R J Kimple; D P Siderovski; F S Willard
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

10.  Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.

Authors:  Emily A Oestreich; Sundeep Malik; Sanjeewa A Goonasekera; Burns C Blaxall; Grant G Kelley; Robert T Dirksen; Alan V Smrcka
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.